| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |